{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-012801","form_type":"8-K","ticker":"SIGA","cik":"0001010086","company_name":"SIGA TECHNOLOGIES INC","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.082847+00:00","generated_at":"2026-06-04T22:43:04.116406+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SIGA Technologies reports 2023 product sales of $131M, pre-tax operating income $84M; declares $0.60 special dividend","bullets":["Product sales increased 51% YoY to $130.7M (including supportive services) for the year ended Dec 31, 2023.","Pre-tax operating income grew 96% to $83.6M; diluted EPS of $0.95 vs $0.46 in 2022.","Board declared special cash dividend of $0.60/share, up from $0.45 last year.","Fourth-quarter product sales surged to $115.7M, driven by $98M oral TPOXX delivery to U.S. SNS.","Over 25 countries ordered oral TPOXX in past two years; EU framework yielded $18M orders in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-012801","json":"https://secwatch.observer/filing/0001140361-24-012801.json","markdown":"https://secwatch.observer/filing/0001140361-24-012801.md","text":"https://secwatch.observer/filing/0001140361-24-012801.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1010086/000114036124012801/0001140361-24-012801-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1010086/000114036124012801/ef20023953_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:43:04.116406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a9f47ff50abf8bb93af203554e38acf420d28ac3","claim":"SIGA TECHNOLOGIES INC reported three and twelve months ended December 31, 2023 results: revenue $131 million in product revenues.","evidence_excerpt":"SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2023. “In 2023, SIGA had approximately $131 million in product revenues and approximately $84 million of pre-tax operating income,” stated Diem Nguyen, Chief Executive Officer.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1010086/000114036124012801/0001140361-24-012801-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and twelve months ended December 31, 2023"},{"label":"Revenue","value":"$131 million in product revenues"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}